Oncolytics Biotech Inc.

210 1167 Kensington Crescent Nw
Calgary, Alberta T2N 1X7
Canada View Map >>

P: (403) 670-7377
F: (403) 283-0858
Oncolytics is a biotechnology company developing REOLYSIN, an immuno-oncology viral-agent, as a potential treatment for a variety of tumor types. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses to treat a variety of cancers. Oncolytics' clinical development program emp... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company

Products & Services

reolysin, anti-cancer products, cancer therapeutic


Biotechnology, Drug Manufacturing & Research, Business Services

Similar Companies

SYNSORB Biotech Inc., Angiotech Pharmaceuticals , Inc., Isotechnika Inc., Neurochem Inc.

Stock Market


SIC Codes

8731, 2834


325412, 541710, 541711

Recently updated profiles at this company (30 contacts available)

Matt Coffey
Chief Operating Officer
Alan Warrander
Senior Vice President, Global Licensing and Business Development
Michael Moore
Vice President, Investor Relations and Corporate Communications
Kirk Look
Chief Financial Officer
Andres Gutierrez
Chief Medical Officer
Allison Hagerman
Director, Manufacturing and Engineering
Merle Crawford
Director, Regulatory and Quality
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory